• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型多发性硬化症中失调细胞因子的细胞来源。

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.

机构信息

Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.

出版信息

J Neuroinflammation. 2012 Sep 14;9:215. doi: 10.1186/1742-2094-9-215.

DOI:10.1186/1742-2094-9-215
PMID:22978757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3503813/
Abstract

BACKGROUND

Numerous cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS), but studies are often limited to whole blood (WB) or peripheral blood mononuclear cells (PBMCs), thereby omitting important information about the cellular origin of the cytokines. Knowledge about the relation between blood and cerebrospinal fluid (CSF) cell expression of cytokines and the cellular source of CSF cytokines is even more scarce.

METHODS

We studied gene expression of a broad panel of cytokines in WB from relapsing-remitting multiple sclerosis (RRMS) patients in remission and healthy controls (HCs). Subsequently we determined the gene expression of the dysregulated cytokines in isolated PBMC subsets (CD4+, CD8+T-cells, NK-cells, B-cells, monocytes and dendritic cells) from RRMS patients and HCs and in CSF-cells from RRMS patients in clinical relapse and non-inflammatory neurological controls (NIND).

RESULTS

RRMS patients had increased expression of IFN-gamma (IFNG), interleukin (IL) 1-beta (IL1B), IL7, IL10, IL12A, IL15, IL23, IL27, lymphotoxin-alpha (LTA) and lymphotoxin-beta (LTB) in WB. In PBMC subsets the main sources of pro-inflammatory cytokines were T- and B-cells, whereas monocytes were the most prominent source of immunoregulatory cytokines. In CSF-cells, RRMS patients had increased expression of IFNG and CD19 and decreased expression of IL10 and CD14 compared to NINDs. CD19 expression correlated with expression of IFNG, IL7, IL12A, IL15 and LTA whereas CD14 expression correlated with IL10 expression.

CONCLUSIONS

Using a systematic approach, we show that expression of pro-inflammatory cytokines in peripheral blood primarily originates from T- and B-cells, with an important exception of IFNG which is most strongly expressed by NK-cells. In CSF-cell studies, B-cells appear to be enriched in RRMS and associated with expression of pro-inflammatory cytokines; contrarily, monocytes are relatively scarce in CSF from RRMS patients and are associated with IL10 expression. Thus, our findings suggest a pathogenetic role of B-cells and an immunoregulatory role of monocytes in RRMS.

摘要

背景

许多细胞因子参与多发性硬化症(MS)的免疫发病机制,但研究通常仅限于全血(WB)或外周血单核细胞(PBMCs),从而忽略了细胞因子的细胞起源的重要信息。关于血液和脑脊液(CSF)细胞中细胞因子表达之间的关系以及 CSF 细胞因子的细胞来源的知识就更加匮乏。

方法

我们研究了缓解期复发型多发性硬化症(RRMS)患者和健康对照者(HCs)的 WB 中广泛细胞因子的基因表达。随后,我们确定了 RRMS 患者和 HCs 中分离的 PBMC 亚群(CD4+、CD8+T 细胞、NK 细胞、B 细胞、单核细胞和树突状细胞)以及 RRMS 患者处于临床复发期和非炎症性神经学对照者(NIND)的 CSF 细胞中失调细胞因子的基因表达。

结果

RRMS 患者的 WB 中 IFN-γ(IFNG)、白细胞介素(IL)1-β(IL1B)、IL7、IL10、IL12A、IL15、IL23、IL27、淋巴毒素-α(LTA)和淋巴毒素-β(LTB)表达增加。在 PBMC 亚群中,促炎细胞因子的主要来源是 T 细胞和 B 细胞,而单核细胞是免疫调节细胞因子的最主要来源。与 NIND 相比,RRMS 患者的 CSF 细胞中 IFNG 和 CD19 表达增加,而 IL10 和 CD14 表达减少。CD19 的表达与 IFNG、IL7、IL12A、IL15 和 LTA 的表达相关,而 CD14 的表达与 IL10 的表达相关。

结论

通过系统的方法,我们发现外周血中促炎细胞因子的表达主要来源于 T 细胞和 B 细胞,IFNG 是一个例外,它主要由 NK 细胞表达。在 CSF 细胞研究中,B 细胞在 RRMS 中似乎更为丰富,并与促炎细胞因子的表达相关;相反,RRMS 患者的 CSF 中单核细胞相对较少,与 IL10 的表达相关。因此,我们的研究结果表明 B 细胞在 RRMS 中具有致病作用,而单核细胞具有免疫调节作用。

相似文献

1
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中失调细胞因子的细胞来源。
J Neuroinflammation. 2012 Sep 14;9:215. doi: 10.1186/1742-2094-9-215.
2
Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis.多发性硬化症外周血单个核细胞亚群研究中合适内参基因的鉴定
Scand J Immunol. 2016 Jan;83(1):72-80. doi: 10.1111/sji.12391.
3
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.趋化因子(CX3CL1)在复发缓解型多发性硬化症患者中对CD4(+)细胞向中枢神经系统迁移的调节作用。
Clin Immunol. 2015 Apr;157(2):121-32. doi: 10.1016/j.clim.2015.01.001. Epub 2015 Jan 14.
4
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.在复发型多发性硬化症患者的脑脊液中,产生 GM-CSF 和 IL-13 的 T 细胞明显增多。
Mult Scler. 2020 Sep;26(10):1172-1186. doi: 10.1177/1352458519852092. Epub 2019 Jun 25.
5
Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.神经炎症性疾病患者脑脊液中的细胞因子和免疫细胞分析。
J Neuroinflammation. 2019 Nov 14;16(1):219. doi: 10.1186/s12974-019-1601-6.
6
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.复发缓解型多发性硬化症患者外周血单个核细胞中的磷酸化信号转导和转录激活因子1(pSTAT1)、磷酸化信号转导和转录激活因子3(pSTAT3)及T盒转录因子(T-bet)表达与疾病活动相关。
J Neurosci Res. 2006 Oct;84(5):1027-36. doi: 10.1002/jnr.20995.
7
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.原发性进行性多发性硬化症中炎症和组织损伤的脑脊液生物标志物之间的关系。
Mult Scler Relat Disord. 2022 Dec;68:104209. doi: 10.1016/j.msard.2022.104209. Epub 2022 Oct 3.
8
Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients.缓解复发型多发性硬化症(MS)患者血浆中的瘦素及其可溶性受体 瘦素对MS患者外周血单个核细胞、T细胞和单核细胞分泌1型和2型细胞因子的体外影响
J Autoimmun. 2004 Sep;23(2):169-77. doi: 10.1016/j.jaut.2004.05.007.
9
Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.多发性硬化症和神经白塞病患者脑脊液中CD39和CD73的差异性表达
Cytokine. 2020 Mar 6;130:155054. doi: 10.1016/j.cyto.2020.155054.
10
Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.多发性硬化症的复发与脑脊液中CD8 + T细胞介导的细胞毒性增加有关。
J Neuroimmunol. 2008 May 30;196(1-2):159-65. doi: 10.1016/j.jneuroim.2008.03.001. Epub 2008 Apr 8.

引用本文的文献

1
The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases.循环细胞因子水平的基因组结构为免疫相关疾病指明了药物靶点。
Commun Biol. 2025 Jan 10;8(1):34. doi: 10.1038/s42003-025-07453-w.
2
Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis.在影响下:环境因素通过 IL-10/IL-10R 轴作为神经炎症的调节剂。
Front Immunol. 2023 Aug 3;14:1188750. doi: 10.3389/fimmu.2023.1188750. eCollection 2023.
3
IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.

本文引用的文献

1
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.遗传风险与细胞介导的免疫机制在多发性硬化中的主要作用。
Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.
2
IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis.白细胞介素-7 促进辅助性 T 细胞 1 型发育,且血清白细胞介素-7 可预测多发性硬化症患者对干扰素-β的临床应答。
Sci Transl Med. 2011 Jul 27;3(93):93ra68. doi: 10.1126/scitranslmed.3002400.
3
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.
白细胞介素-2、白细胞介素-6 和几丁质酶 3 样蛋白 2 可能预测多发性硬化症的早期复发活动。
PLoS One. 2022 Jun 27;17(6):e0270607. doi: 10.1371/journal.pone.0270607. eCollection 2022.
4
Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models.通过靶向惩罚回归模型捕获多发性硬化症中 NK 受体和 HLA 基因区域的 SNP 关联。
Genes (Basel). 2021 Dec 29;13(1):87. doi: 10.3390/genes13010087.
5
IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study.白细胞介素 27 T4730C 多态性与多发性硬化症的血清学研究:一项初步研究。
In Vivo. 2021 Sep-Oct;35(5):2845-2853. doi: 10.21873/invivo.12572.
6
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.基因组学、蛋白质组学和系统生物学方法在多发性硬化症生物标志物发现中的应用。
Cell Immunol. 2020 Dec;358:104219. doi: 10.1016/j.cellimm.2020.104219. Epub 2020 Sep 20.
7
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.多发性硬化症患者 Th17 细胞中炎症特征的独特表达。
Cells. 2019 Jun 4;8(6):533. doi: 10.3390/cells8060533.
8
The Cerebrospinal Fluid in Multiple Sclerosis.多发性硬化症中的脑脊液。
Front Immunol. 2019 Apr 12;10:726. doi: 10.3389/fimmu.2019.00726. eCollection 2019.
9
Genome-wide DNA methylation changes in CD19 B cells from relapsing-remitting multiple sclerosis patients.复发缓解型多发性硬化症患者 CD19 B 细胞中的全基因组 DNA 甲基化变化。
Sci Rep. 2018 Nov 27;8(1):17418. doi: 10.1038/s41598-018-35603-0.
10
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?多发性硬化症中的调节性B淋巴细胞和T淋巴细胞:是友还是敌?
Auto Immun Highlights. 2018 Nov 10;9(1):9. doi: 10.1007/s13317-018-0109-x.
细胞因子 mRNA 谱分析表明 B 细胞是类风湿关节炎中 RANKL 的主要来源。
Ann Rheum Dis. 2011 Nov;70(11):2022-8. doi: 10.1136/ard.2011.153312. Epub 2011 Jul 8.
4
The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis.血管内皮生长因子 A 的表达在复发性进展型多发性硬化症患者的外周血单个核细胞中被下调。
PLoS One. 2011 May 6;6(5):e19138. doi: 10.1371/journal.pone.0019138.
5
Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.多发性硬化症患者促炎细胞因子和趋化因子 mRNA 血液水平与治疗反应和干扰素-β剂量有关。
J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23.
6
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?多发性硬化症中内源性干扰素-β对疾病的保护和白介素-10 的诱导作用?
Eur J Neurol. 2011 Feb;18(2):266-272. doi: 10.1111/j.1468-1331.2010.03116.x.
7
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?异常 B 细胞细胞因子反应是 MS 中 T 细胞介导疾病的触发因素吗?
Ann Neurol. 2010 Apr;67(4):452-61. doi: 10.1002/ana.21939.
8
Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.白细胞介素-15 基因敲除小鼠实验性自身免疫性脑脊髓炎加重。
Exp Neurol. 2010 Apr;222(2):235-42. doi: 10.1016/j.expneurol.2009.12.034. Epub 2010 Jan 11.
9
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.多发性硬化症中表达干扰素-γ的TH17细胞的优先募集。
Ann Neurol. 2009 Sep;66(3):390-402. doi: 10.1002/ana.21748.
10
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.那他珠单抗对多发性硬化症炎症介质的影响:治疗敏感性生物标志物的前景
Eur J Neurol. 2009 Apr;16(4):528-36. doi: 10.1111/j.1468-1331.2009.02532.x.